COMMUNIQUÉS West-GlobeNewswire

XBiotech annonce la présentation des données de l'étude de phase 2 pour l'évaluation de MABp1 dans le traitement de l'hidradénite suppurée
07/09/2017
Résultats de l'étude de phase 2 randomisée pour l'évaluation de MABp1 dans le traitement de l'hidradénite suppurée AUSTIN, Texas, le 7 septembre 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd' [...]
The International Association for the Study of Lung Cancer Announces Abstract Selections for the 18th World Conference on Lung Cancer
07/09/2017
Groundbreaking research will shed light on the newest advances in the study of lung cancer DENVER, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The International Association for the Study of Lung Cancer (IASLC) announced today [...]
Inivata: Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Network
07/09/2017
Inivata Announces Strategic Partnership with Levine Cancer Institute and Formation of the Inivata Knowledge Accumulation Network This network will bring together global leaders in cancer care to unlock the potential of [...]
SPINEWAY : Poursuite du déploiement aux USA Nouveau distributeur au Texas
07/09/2017
Communiqué de presse Ecully, le 7 septembre 2017 Poursuite du déploiement aux USA Nouveau distributeur au Texas Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des pathologies de la [...]
SPINEWAY : Continued expansion in the USA New distributor in Texas
07/09/2017
Press release Ecully, 7 September 2017 Continued expansion in the USA New distributor in Texas Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has just [...]
ThromboGenics Business Update - H1 2017
07/09/2017
Press release 7 September, 2017 Regulated Information Good Progress in Advancing Diabetic Eye Disease Portfolio Oncurious NV grows pipeline with 5 immuno-oncology assets from VIB Cash Position - €65.1 Million end H1 [...]
Medtronic Chairman and CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare Conference
07/09/2017
DUBLIN - September 7, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 15th Annual Morgan Stanley Global Healthcare Conference on Monday, [...]
Arix Bioscience plc notes positive trial data from Verona Pharma in COPD
07/09/2017
Arix Bioscience plc notes positive trial data from Verona Pharma in COPD LONDON, 7 September 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life science company supporting medical [...]
Nuvaira Announces Four Clinical Abstracts Accepted for Presentation at ERS International Congress
07/09/2017
Treating COPD and Asthma with Targeted Lung Denervation is Focus of Mini-Symposium MILAN, Italy, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Nuvaira , a developer of medical devices to treat obstructive lung diseases, today [...]
XBiotech Announces Presentation of Phase 2 Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa
07/09/2017
Results of the Randomized Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurati AUSTIN, Texas, Sept. 07, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that results from the [...]
Nuvaira annonce la sélection de quatre rapports cliniques pour présentation lors du Congrès international de la SRE
07/09/2017
Le traitement des maladies pulmonaires obstructives chroniques (MPOC) et de l'asthme par dénervation pulmonaire ciblée fera l'objet d'un mini-colloque MILAN, Italie, le 7 septembre 2017 (GLOBE NEWSWIRE) - Nuvaira , un [...]
GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO
07/09/2017
PHILADELPHIA and OXFORD, United Kingdom, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that GlaxoSmithKline plc (LSE:GSK) ( [...]
Sanofi Alliance Partner Alnylam Gives Update on Fitusiran
07/09/2017
Sanofi Alliance Partner Alnylam Provides Update on Fitusiran Development Program Paris, France - September 7, 2017 - Sanofi alliance partner Alnylam Pharmaceuticals today provided an update on the clinical development [...]
Le partenaire de Sanofi, Alnylam, fait le point sur le programme de développement du fitusiran
07/09/2017
Le partenaire de Sanofi, Alnylam, fait le point sur le programme de développement du fitusiran Paris, France - Le 7 septembre 2017 - Le partenaire de Sanofi , Alnylam Pharmaceuticals, a fait le point aujourd'hui sur le [...]
Medtronic Recognized for Its Sustainability Leadership
07/09/2017
Company Marks a Decade on the North American Dow Jones Sustainability Index (DJSI) DUBLIN - September 7, 2017 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability [...]
Shire to participate at two upcoming investor conferences
07/09/2017
Shire to participate at two upcoming investor conferences Lexington, MA, USA - September 7, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming Ornskov, MD, Chief Executive Officer, will present at the [...]
Zealand and Orbit Discovery enter into research collaboration
07/09/2017
Company announcement - No. 45 / 2017 Zealand and Orbit Discovery enter into research collaboration Combining Zealand's expertise in discovery and development of peptide therapeutics with Orbit's unique peptide libraries [...]
Helsinn Group supports prIME's Satellite Symposium at ESMO 2017
07/09/2017
Helsinn Group supports prIME's Satellite Symposium at ESMO 2017 World-renowned supportive care experts in oncology explore how to provide the best care for patients by incorporating patient-reported outcomes into the [...]
Verona Pharma Announces Positive Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)
07/09/2017
Achieved significant and clinically meaningful additional improvement in peak lung function and faster onset-of-action when added to tiotropium Demonstrated statistical significance across all primary and secondary [...]

Pages